FB2026_02 , released June 18, 2026
Human Disease Model Report: cerebral amyloid angiopathy, ITM2B-related, 2
Open Close
General Information
Name
cerebral amyloid angiopathy, ITM2B-related, 2
FlyBase ID
FBhh0000250
Overview

One of several autosomal dominant diseases associated with defects in integral membrane protein 2B (ITM2B); also known as familial Danish dementia (FDD). See the human disease model report for cerebral amyloid angiopathy, ITM2B-related (FBhh0000245).

Variant(s) implicated in human disease tested (as transgenic human gene, ITM2B): the Danish variant form (NM_021999. 4:c.786_795dupTTTAATTTGT ) have been introduced into flies; this mutation results in a carboxy extension of the protein.

[updated Jul. 2017 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: cerebral amyloid angiopathy
Symptoms and phenotype

Cerebral amyloid angiopathy (CAA), or cerebroarterial amyloidosis, refers to a pathologic process in which amyloid protein progressively deposits in cerebral blood vessel walls with subsequent degenerative vascular changes that usually result in spontaneous cerebral hemorrhage, recurrent headaches, ischemic lesions, hemorrhagic strokes, and progressive dementia (Revesz et al., 2003; pubmed: 14533778). [from MIM:605714; 2017.06.02]

Cerebral amyloid angiopathy (CAA) refers to the deposition of β-amyloid in the walls of the blood vessels of the central nervous system. It is a component of any disorder in which amyloid is deposited in the brain; it is not associated with systemic amyloidosis. While often asymptomatic, CAA may lead to dementia, intracranial hemorrhage, or transient neurologic events. [http://emedicine.medscape.com/article/1162720-overview, 2017.07.14]

Specific Disease Summary: cerebral amyloid angiopathy, ITM2B-related, 2
OMIM report

[CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2](https://omim.org/entry/117300)

Human gene(s) implicated

[INTEGRAL MEMBRANE PROTEIN 2B; ITM2B](https://omim.org/entry/603904)

Symptoms and phenotype

Cataracts are typically the first manifestation of cerebral amyloid angiopathy, ITM2B-related, 2, starting before the age of 30, whereas impaired hearing usually develops 10 to 20 years later. Cerebellar ataxia occurs shortly after the age of 40, followed by paranoid psychosis and dementia 10 years later. Most patients die in their fifth to sixth decade of life. [from MIM:117300; 2016.04.12]

Genetics

This disorder is caused by mutation in the integral membrane protein 2B (ITM2B) gene (also called the BRI2 gene); it is inheritied as an autosomal dominant. [from MIM:176500; 2016.04.12]

The specific genetic lesion in cerebral amyloid angiopathy, ITM2B-related, 2 is a 10-bp duplication at nt795, which is near the end of the CDS; results in a carboxy extension. [from MIM:603904; 2016.04.12]

Cellular phenotype and pathology

Like Alzheimer disease, cerebral amyloid angiopathy, ITM2B-related, 1 and 2 are associated with amyloid deposition and neurodegeneration in the central nervous system. [from MIM:117300; 2016.04.12]

Molecular information
External links
Disease synonyms
cerebellar ataxia, cataract, deafness, and dementia or psychosis
cerebral amyloid angiopathy, Danish type
familial Danish dementia
FDD
heredopathia ophthalmootoencephalica
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 3 human to 1 Drosophila; additional human orthologous genes are ITM2A and ITM2C.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (0)
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (0 groups)
      Alleles Reported to Model Human Disease (Disease Ontology) (7 alleles)
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      References (4)